Email this article 
Treatment of acne in women with various forms of hyperandrogenism
- Authors: Golousenko Y.Y.1, Perlamutrov Y.N1
-
Affiliations:
- Issue: Vol 86, No 5 (2010)
- Pages: 74-76
- Section: Articles
- URL: https://vestnikdv.ru/jour/article/view/957
- DOI: https://doi.org/10.25208/vdv957
- Cite item
Full Text
Abstract
The authors conducted a study of the urine steroid profile in 56 women with acne in order to determine the form of their hyperandrogenism
(HA). A ovarian form of HA was revealed in 28.7% of patients, a mixed form was revealed in 30.9%, and no laboratory
signs of any hyperandrogenic state were revealed in 40.4%. The determination of the HA form enabled the authors to efficiently
select a method of systemic treatment for the patients with the use of hormone drugs and to achieve excellent and good results in
70.4% for women with the ovarian form of HA and in 75.9% for women with the mixed form. As for the group of patients where no
HA form was determined, good and excellent results were observed in 30.4% of women.
(HA). A ovarian form of HA was revealed in 28.7% of patients, a mixed form was revealed in 30.9%, and no laboratory
signs of any hyperandrogenic state were revealed in 40.4%. The determination of the HA form enabled the authors to efficiently
select a method of systemic treatment for the patients with the use of hormone drugs and to achieve excellent and good results in
70.4% for women with the ovarian form of HA and in 75.9% for women with the mixed form. As for the group of patients where no
HA form was determined, good and excellent results were observed in 30.4% of women.
Keywords
References
- Роговская С.И., Телунц А.В., Савельева И.С. Акне как проявление синдрома гиперандрогении: методы коррекции. Provisorum. 2002; (8): 28-29.
- Серов В.Н., Никитин С.В. Новые возможности лечебного действия комбинированных оральных контрацептивов. Гинекология. 2000; 2 (6).
- Дедов И.И., Андреева Е.Н., Пищулин А.А. Синдром гиперандрогении у женщин. Методическое пособие для врачей. М., 2006; 3-40.
